Cargando…

Metformin and Cancer Glucose Metabolism: At the Bench or at the Bedside?

Several studies reported that metformin, the most widely used drug for type 2 diabetes, might affect cancer aggressiveness. The biguanide seems to directly impair cancer energy asset, with the consequent phosphorylation of AMP-activated protein kinase (AMPK) inhibiting cell proliferation and tumor g...

Descripción completa

Detalles Bibliográficos
Autores principales: Marini, Cecilia, Cossu, Vanessa, Bauckneht, Matteo, Lanfranchi, Francesco, Raffa, Stefano, Orengo, Anna Maria, Ravera, Silvia, Bruno, Silvia, Sambuceti, Gianmario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392176/
https://www.ncbi.nlm.nih.gov/pubmed/34439897
http://dx.doi.org/10.3390/biom11081231

Ejemplares similares